On October 25, 2022 DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, reported the speaker lineup for its customer presentations at the American Society of Human Genetics (ASHG) 2022 Annual Meeting, which is being held in Los Angeles this week (Press release, DNAnexus, OCT 25, 2022, View Source [SID1234622362]). The company will also be showcasing its GxP-compliant platform and new Nextflow pipeline language support capabilities in booth #2103.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"The rapidly evolving genomic and multi-omic ecosystem has created an enormous need for a scalable and compliant analysis platform that drives critical insights from massive datasets," said Stephen Nuckols, Chief Commercial Officer at DNAnexus. "We look forward to hearing from several visionary scientists about how they are using our platform to push the boundaries of human genetics and tackle the most exciting opportunities in precision medicine."
FEATURED PRESENTATIONS
Using Genomic Data to Drive Precision Medicine Insights
Partnering with DNAnexus to Unlock Myriad’s Precise Treatment Registry
Kevin Haas, PhD, Chief Technology Officer, Myriad Genetics
The City of Hope POSEIDON Platform: Driving Cancer Insights with Real-World Data
Samir Courdy, Senior Vice President and Chief Informatics Officer, City of Hope
Detection of Clonal Hematopoiesis in the UK Biobank and Association with Health Outcomes
Kelly Bolton, MD, PhD, Assistant Professor, Washington University School of Medicine
Ben Busby, PhD, Senior Director of Solution Science, DNAnexus
To register for these presentations, please visit: View Source
Today, DNAnexus has more than 12,000 users across 48 countries and works with the largest and most innovative pharmaceutical companies, diagnostic laboratories, and academic medical centers around the world, along with the UK Biobank and the FDA. The platform provides a comprehensive cloud environment that was designed to meet the most rigorous standards for quality, security, privacy, and safety.